Beyond Condoms

1. Front Matter

   Pages i-xx

   PDF

2. Negotiated Safety Agreements Among Gay Men

   • Susan Kippax

   Pages 1-15

3. Structural Barriers and Facilitators in HIV Prevention: A Review of International Research

   • Charles Klein, Delia Easton, Richard Parker

   Pages 17-46

4. Female-Controlled Prevention Technologies

   • Janet S. Moore, Martha Rogers

   Pages 47-76

5. STD Diagnosis and Treatment as an HIV Prevention Strategy

   • Sevgi O. Aral, Thomas A. Peterman

   Pages 77-90

6. HIV Treatment Advances as Prevention

   • Lynn Paxton, Robert Janssen

   Pages 91-108

7. The Abstinence Strategy for Reducing Sexual Risk Behavior

   • John B. Jemmott III, Dana Fry

   Pages 109-137

8. Assessing the Cost-effectiveness of Alternative Approaches to HIV Prevention

   • Steven D. Pinkerton, David R. Holtgrave

   Pages 139-171

9. “Gray Area Behaviors” and Partner Selection Strategies

   • Richard J. Wolitski, Bernard M. Branson

   Pages 173-198

10. Selective Serotonin Reuptake Inhibitors as a Treatment for Sexual Compulsivity

    • Troy Suarez, Ann O’Leary, Jon Morgenstern, Andrea Allen, Eric Hollander

    Pages 199-220

11. Prevention Triage: Optimizing Multiple HIV Intervention Strategies

    • Ann O’Leary, Thomas Peterman, Sevgi O. Aral

    Pages 221-231

12. Back Matter

    Pages 233-242

    PDF

Our contemporary division of the progress of time should be delineated as B. A. E. (Before the AIDS Epidemic, i. e. , 1981) and P. A. E. Everyone keeps predicting the end of the epidemic, as Newsweek did in 1996 when combination therapy was introduced. But as far as we can tell from this vantage point, the virus continues, albeit a bit hobbled by a few drugs here and there, but moving forward nonetheless. Predictions are that over 100 million people will be infected with HIV by 2005. It is also clear that the number of people living with HIV in the US and other developed countries will continue to grow, as people with HIV live longer and better lives, but, paradoxically and perhaps as a result, the number of people acquiring HIV also continues to grow. HIV vaccines are at least 20, and perhaps 40 years away. When they do come on board, they may not prevent infection but may, instead, change the course of illness in those infected and hopefully render them less infectious. Further, the first vaccines will, in all likelihood, be less than 100% effective. The next generation of prevention strategies need to combine the best of biomedical, social, and behavioral approaches in order to protect the population. The male condom, along with reduction in the number of sexual partners or outright abstinence, have been the mainstay of HIV prevention.

• HIV
• HIV prevention
• Public Health
• prevention
• prevention strategies
• virus

• Centers for Disease Control and Prevention, Atlanta

  Ann O’Leary

Policies and ethics